Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
AbstractAlthough surgery is the most effective treatment for liver metastases in colorectal cancer patients, only 15-20% of these patients are suitable for a radical surgical approach, and metastases recurrence may occur at follow up. In the last decade, the use of pre-operative chemotherapy in combination with new biological drugs has been introduced. We reviewed data of neo-adjuvant chemotherapy strategies aimed at increasing the resection rate of liver metastases in colorectal cancer patients who were initially considered unresectable.
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.
Copyright (c) 2012 Luigi Rossi, Angelo Zullo, Federica Zoratto, Anselmo Papa, Martina Strudel, Maria Colonna, Silverio Tomao
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.